However, both protein and mRNA levels of BDNF in the brain decrease in AD compared to healthy aging45–49, suggesting that BDNF might be an important regulator of synaptic plasticity to influence NE release, which is perturbed in advanced AD pathology. Here, BDNF is linked to Alzheimer disease.